Psyence Biomedical Ltd (PBM) concluded trading on Wednesday at a closing price of $1.34, with 4.05 million shares of worth about $5.42 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -96.46% during that period and on Wednesday the price saw a gain of about 10.74%. Currently the company’s common shares owned by public are about 0.72M shares, out of which, 0.68M shares are available for trading.
Stock saw a price change of -2.19% in past 5 days and over the past one month there was a price change of -20.24%. Year-to-date (YTD), PBM shares are showing a performance of -36.49% which decreased to -96.72% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.13 but also hit the highest price of $323.25 during that period. The average intraday trading volume for Psyence Biomedical Ltd shares is 2.69 million. The stock is currently trading -2.85% below its 20-day simple moving average (SMA20), while that difference is down -22.44% for SMA50 and it goes to -93.20% lower than SMA200.
Psyence Biomedical Ltd (NASDAQ: PBM) currently have 0.72M outstanding shares and institutions hold larger chunk of about 93.39% of that.
The stock has a current market capitalization of $5.24M and its 3Y-monthly beta is at -0.44. It has Quick Ratio of 0.64. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PBM, volatility over the week remained 9.36% while standing at 13.82% over the month.
